Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paraquat is a potent, non-selective bipyridinium herbicide that is highly toxic to humans and animals rather than being a therapeutic drug target (Source: PubChem CID 15930). Its biological impact is defined by its ability to undergo rapid redox cycling, a process that converts molecular oxygen into highly reactive superoxide radicals, leading to systemic oxidative stress and the depletion of cellular reducing equivalents like NADPH (Source: StatPearls, Paraquat Toxicity). In clinical toxicology, paraquat is significant due to its active accumulation in the lungs and kidneys via polyamine transporters, often resulting in fatal multi-organ failure and a characteristic progressive pulmonary fibrosis (Source: NIH, PubMed). While it has no medical application, paraquat is a widely utilized chemical tool in laboratory research to create experimental models of Parkinson's disease, as its mechanism of action mimics the oxidative stress-induced degeneration of dopaminergic neurons observed in neurodegenerative pathologies (Source: Wikipedia, CDC).
Paraquat induces cellular toxicity through a catalytic redox cycling mechanism. Within the cell, it is reduced by various diaphorases, notably NADPH-cytochrome P450 reductase, to form a paraquat mono-cation radical. This radical then reacts rapidly with molecular oxygen to regenerate the parent paraquat cation and produce superoxide anions (O2•-). This continuous cycle leads to the exhaustion of cellular NADPH and the generation of reactive oxygen species (ROS), which initiate lipid peroxidation and cause extensive damage to cellular membranes and mitochondria (Source: StatPearls, PubChem).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paraquat (PQ).